Novavax, Inc. (NASDAQ: NVAX) has experienced a significant surge in its stock performance, buoyed by the unveiling of its financial outcomes. In the latest market
Sonoma Pharmaceuticals Inc. (SNOA) stock plunged -7.53% to $8.1 in the pre-market trading after reporting partnership with Crown Laboratories to launch Microcyn® technology-based anti-itch over-the-counter
BlackBerry Limited (BB) stock soared 21.29% to $8.49 in the pre-market trading following the announcement of its multi-year, global agreement with Amazon Web Services, Inc.
Novavax Inc’s (NVAX) stock was up 1.73% to trade at $125.6 in the premarket session today, despite the recent news that the company has again
Moderna Inc (MRNA) was up 20.24%on Monday at $152.74. The biotechnology company has therefore applied for marketing authorizations for its coronavirus vaccine in the United
China Automotive Systems Inc. (CAAS) stock soared 2.38% to $10.75 in the pre-market trading after reporting that it shipped approximately 120,000 units from its portfolio
FuelCell Energy Inc. (FCEL) stock soared 4.75% to $10.15 in the pre-market trading. The most recent rating by JP Morgan, on November 19, 2020, is
IMAC Holdings Inc. (IMAC) stock plunged -13.16% to $1.32 in the pre-market trading after the company reported third-quarter earnings. The most recent rating by Ascendiant
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.